United Therapeutics (UTHR) Stock Price
$307 0.3%
to add to portfolio
AI Score
-
Alternative
4 -
Fundamental
10 -
Technical
4
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on United Therapeutics, AI stock picks, stock alerts and much more.
UTHR AI Stock Analysis
Financial Performance
United Therapeutics has shown a consistent growth in revenue, gross profit and operating income over the last quarter as well as year-over-year. The EBITDA ratio of 0.56 indicates that the company is generating more than half of its revenue as earnings before interest, taxes, depreciation and amortization which shows operational efficiency.
Stock Price
The stock price is on an upward trend with a significant year-over-year increase of 72.5%. The RSI value at 57.34 suggests the stock is neither overbought nor oversold while the stock's price being above its 200-day moving average indicates a positive trend for investors.
Alternative Data Signals
The company's web traffic has seen considerable growth both month-over-month and year-over-year which reflects increased digital engagement. However, there has been a decrease in job openings indicating potential slowdown in expansion or hiring process. Employee sentiment seems to be generally positive about business outlook but there is mixed performance on social media followers count with decrease on Twitter and Instagram but an increase on Facebook.
Conclusion
In conclusion, United Therapeutics' financial performance and stock trends indicate a bullish outlook for investors despite some mixed signals from alternative data sources such as social media following and job postings.
Note: This AI Stock Analysis is based on data as of February 15. Our members can refresh and get access to an up-to-date AI stock analysis.
Sign up
United Therapeutics (UTHR) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of United Therapeutics (UTHR), currently trading at $307, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About UTHR
-
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.
-
Symbol
UTHR
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
13.8B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$24.69 0.6% |
4 |
 |
Inovio Pharmaceuticals INO |
$1.73 1.7% |
1 |
 |
Moderna MRNA |
$31.12 3.1% |
3 |
 |
Anavex Life Sciences AVXL |
$8.72 8.6% |
5 |
 |
BridgeBio Pharma BBIO |
$35.11 3.5% |
5 |
News
UTHR Alternative Data
Web Traffic
United Therapeutics receives an estimated 24225 monthly visitors to unither.com.
-
Web Traffic
24225
-
Change from Previous Month
8.8%
-
3 Month Change
8.6%
-
YoY Change
8.6%
News Mentions
United Therapeutics was mentioned 56 times in the news yesterday.
-
News Mentions
56
-
Daily Change
0%
-
1 Month Change
47.4%
-
3 Month Change
12%
Reddit Mentions
United Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
100%
Twitter Followers
United Therapeutics has 195 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.5% over the last month.
-
Twitter Followers
195
-
Daily Change
0%
-
1 Month Change
0.5%
-
3 Month Change
0.5%
-
YoY Change
0.5%
Facebook Engagement
United Therapeutics has engaged 3 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
3
-
Daily Change
62.5%
-
1 Month Change
81.3%
-
3 Month Change
97.2%
-
YoY Change
97.2%
Instagram Followers
United Therapeutics has 73 Instagram Followers on its main Instagram account.
-
Instagram Followers
73
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
LinkedIn Followers
35,185 are following United Therapeutics on LinkedIn, up by 2.3% over the last month.
-
LinkedIn Followers
35185
-
Daily Change
0.1%
-
1 Month Change
2.3%
-
3 Month Change
7.8%
Job Postings
United Therapeutics currenly has an estimated 46 open job postings, up by 15% over the last month.
-
Job Postings
46
-
Daily Change
7%
-
1 Month Change
15%
-
3 Month Change
4.5%
-
YoY Change
4.5%
LinkedIn Employees
According to LinkedIn, United Therapeutics has 1,259 employees, up by 1.3% over the last month.
-
LinkedIn Employees
1259
-
Daily Change
0%
-
1 Month Change
1.3%
-
3 Month Change
2.8%
-
YoY Change
2.8%
Business Outlook
According to employee reviews, the business outlook among employees at United Therapeutics is 79 out of 100 (bullish).
-
Business Outlook
79
-
Change from Previous Month
2.6%
-
3 Month Change
0%
-
YoY Change
0%
UTHR Financials
UTHR Key Metrics
-
Total Revenue
$735.9M
-
Net Income
$301.3M
-
Earnings per Share
$6.74
-
Free cash flow
$254.5M
-
EBITDA
$424.1M
-
EBITDA Ratio
0.576301
-
Total Assets
$7.4B
UTHR 2-year Revenue & Income
UTHR 2-year Free Cash Flow
UTHR Technicals
UTHR SMA
UTHR RSI
FAQ
What's the current price of United Therapeutics (UTHR) Stock?
The price of an United Therapeutics (UTHR) share is $307.
What's the market cap of United Therapeutics?
The current market cap of United Therapeutics is 13.8B.
Should I buy or sell UTHR?
Multiple alternative data signals suggest that United Therapeutics stock could offer a buying opportunity at its current level, with a reasonable expectation for positive performance in the mid term.
Is United Therapeutics a good investment?
Based on an in-depth analysis that encompasses fundamentals, technical analysis, and alternative data insights, it appears to be a favorable time to consider investing in United Therapeutics stock. The bullish indicators suggest that United Therapeutics' growth prospects and market position may lead to a positive performance in the foreseeable future.
Is now a good time to buy United Therapeutics (UTHR) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it could be a favorable time to consider buying United Therapeutics stock, given the bullish outlook.
What are some stocks similar to United Therapeutics (UTHR) that investors often compare it to?
United Therapeutics (UTHR) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for United Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast United Therapeutics' stock price to be around $328.4 in 2026. Starting from the current price of $307, this represents a 7% change in price, indicating a bullish outlook for the stock.
How to buy United Therapeutics (UTHR) Stock?
United Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy United Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.